BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9711675)

  • 1. Androgen metabolism and the menopause.
    Longcope C
    Semin Reprod Endocrinol; 1998; 16(2):111-5. PubMed ID: 9711675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P; Wójtowicz M; Sikora J
    Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.
    Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1990 Sep; 71(3):696-704. PubMed ID: 2144295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine evaluation of patients with benign lumps of the breast.
    Mancini A; di Pietro C; de Marinis L; Rossi S; Lombardi CP; Iacona T; Bellantone R; Liberale I; Menini E; Crucitti F
    Cancer Detect Prev; 1992; 16(1):27-30. PubMed ID: 1532347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone metabolism.
    Longcope C
    J Endocrinol; 1996 Sep; 150 Suppl():S125-7. PubMed ID: 8943796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aging ovary.
    Shifren JL; Schiff I
    J Womens Health Gend Based Med; 2000; 9 Suppl 1():S3-7. PubMed ID: 10695867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
    Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen physiology.
    Davison SL; Bell R
    Semin Reprod Med; 2006 Apr; 24(2):71-7. PubMed ID: 16633980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
    Labrie F; Labrie C
    Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM; Thomas CM; Borm GF; Rolland R
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen and estrogen dynamics in the female baboon (Papio anubis).
    Longcope C; Femino A; Johnston JO
    J Steroid Biochem; 1988 Aug; 31(2):195-200. PubMed ID: 3404989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in circulating steroids with aging in postmenopausal women.
    Meldrum DR; Davidson BJ; Tataryn IV; Judd HL
    Obstet Gynecol; 1981 May; 57(5):624-8. PubMed ID: 7219911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen replacement therapy in women: myths and realities.
    Casson PR; Carson SA
    Int J Fertil Menopausal Stud; 1996; 41(4):412-22. PubMed ID: 8894799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of direct and indirect markers to assess the androgen status in healthy males during aging.
    Elmlinger MW; Kühnel W; Döller PC
    Clin Lab; 2006; 52(9-10):491-6. PubMed ID: 17078476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction.
    Guay A; Munarriz R; Jacobson J; Talakoub L; Traish A; Quirk F; Goldstein I; Spark R
    Int J Impot Res; 2004 Apr; 16(2):112-20. PubMed ID: 14999217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women.
    Overlie I; Moen MH; Morkrid L; Skjaeraasen JS; Holte A
    Acta Obstet Gynecol Scand; 1999 Aug; 78(7):642-7. PubMed ID: 10422913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenopause or decline of serum adrenal androgens with age in women living at sea level or at high altitude.
    Gonzales GF; Góñez C; Villena A
    J Endocrinol; 2002 Apr; 173(1):95-101. PubMed ID: 11927388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.